Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$35.91−0.53 (-1.45%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Nektar Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Nektar Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 15.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.3×, with a median of 1.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −8.9 |
| 2025 | Dec 31, 2025 | 9.8× | +6.3 |
| 2024 | Dec 31, 2024 | 3.5× | +2.8 |
| 2023 | Dec 29, 2023 | 0.7× | −0.4 |
| 2022 | Dec 30, 2022 | 1.0× | −2.1 |
| 2021 | Dec 31, 2021 | 3.1× | +0.5 |
| 2020 | Dec 31, 2020 | 2.6× | +0.1 |
| 2019 | Dec 31, 2019 | 2.5× | −0.6 |
| 2018 | Dec 31, 2018 | 3.2× | −108.2 |
| 2017 | Dec 29, 2017 | 111.4× | −218.6 |
| 2016 | Apr 29, 2016 | 330.0× | +272.5 |
| 2015 | Dec 31, 2015 | 57.5× | +15.4 |
| 2014 | Dec 31, 2014 | 42.1× | +15.5 |
| 2013 | Apr 30, 2013 | 26.6× | +17.6 |
| 2012 | Dec 31, 2012 | 8.9× | +6.2 |
| 2011 | Dec 30, 2011 | 2.8× | – |
See a number that looks wrong?